Generation and potential biomedical applications of embryonic stem cell-derived glial precursors

Journal of the Neurological Sciences

Volumn 265, Issue 1-2, 2008, Pages 47-58

  Glaser, Tamara ^a   Schmandt, Tanja ^a   Brüstle, Oliver ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Animal models; Cell based therapies; Embryonic stem cells; Multiple sclerosis; Myelin; Oligodendrocytes; Transplantation

Indexed keywords

CEREBROSIDE SULFATASE; ETHIDIUM BROMIDE; FIBROBLAST GROWTH FACTOR 2; LIOTHYRONINE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR; RETINOIC ACID; SODIUM CALCIUM EXCHANGE PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL THERAPY; CELL TYPE; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; DRUG DELIVERY SYSTEM; EMBRYONIC STEM CELL; GENE TARGETING; GENE TRANSFER; GLIA CELL; HUMAN; MEDICAL RESEARCH; NERVE CELL; NERVOUS SYSTEM; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; REMYELINIZATION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASES; EMBRYONIC STEM CELLS; HUMANS; NEUROGLIA; STEM CELL TRANSPLANTATION;

EID: 37849009445     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.09.018     Document Type: Article

References (172)

1. Bruck W., Kuhlmann T., and Stadelmann C. Remyelination in multiple sclerosis. J Neurol Sci 206 (2003) 181-185
2. Smith K.J., Blakemore W.F., and McDonald W.I. The restoration of conduction by central remyelination. Brain 104 (1981) 383-404
3. Murray P.D., McGavern D.B., Sathornsumetee S., and Rodriguez M. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. Brain 124 (2001) 1403-1416
4. Chari D.M., and Blakemore W.F. New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation. Mult Scler 8 (2002) 271-277
5. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 3 (2002) 705-714
6. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998) 278-285
7. Bjartmar C., and Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14 (2001) 271-278
8. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120 Pt 3 (1997) 393-399
9. Kornek B., and Lassmann H. Axonal pathology in multiple sclerosis. A historical note. Brain Pathol 9 (1999) 651-656
10. Rammohan K.W. Axonal injury in multiple sclerosis. Curr Neurol Neurosci Rep 3 (2003) 231-237
11. Bruck W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 252 Suppl 5 (2005) v3-v9
12. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., and Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 Pt 6 (2000) 1174-1183
13. Pitt D., Werner P., and Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6 (2000) 67-70
14. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36 (1994) 778-786
15. Brosnan C.F., Battistini L., Raine C.S., Dickson D.W., Casadevall A., and Lee S.C. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 16 (1994) 152-161
16. Smith K.J., Kapoor R., and Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9 (1999) 69-92
17. Garthwaite G., Goodwin D.A., Batchelor A.M., Leeming K., and Garthwaite J. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 109 (2002) 145-155
18. Smith K.J., Kapoor R., Hall S.M., and Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49 (2001) 470-476
19. Kapoor R., Davies M., and Smith K.J. Temporary axonal conduction block and axonal loss in inflammatory neurological disease. A potential role for nitric oxide?. Ann N Y Acad Sci 893 (1999) 304-308
20. Kapoor R., Davies M., Blaker P.A., Hall S.M., and Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 53 (2003) 174-180
21. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 206 (2003) 187-191
22. Stys P.K., Waxman S.G., and Ransom B.R. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci 12 (1992) 430-439
23. Stys P.K., Sontheimer H., Ransom B.R., and Waxman S.G. Noninactivating, tetrodotoxin-sensitive Na+ conductance in rat optic nerve axons. Proc Natl Acad Sci U S A 90 (1993) 6976-6980
24. Stys P.K., Ransom B.R., Waxman S.G., and Davis P.K. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci U S A 87 (1990) 4212-4216
25. LoPachin R.M., and Lehning E.J. Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 143 (1997) 233-244
26. Stys P.K., Ransom B.R., and Waxman S.G. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 67 (1992) 236-240
27. Rosenberg L.J., Teng Y.D., and Wrathall J.R. Effects of the sodium channel blocker tetrodotoxin on acute white matter pathology after experimental contusive spinal cord injury. J Neurosci 19 (1999) 6122-6133
28. Lo A.C., Black J.A., and Waxman S.G. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport 13 (2002) 1909-1912
29. Lo A.C., Saab C.Y., Black J.A., and Waxman S.G. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 90 (2003) 3566-3571
30. Bechtold D.A., Kapoor R., and Smith K.J. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 55 (2004) 607-616
31. Filippini G., Munari L., Incorvaia B., Ebers G.C., Polman C., D'Amico R., et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 361 (2003) 545-552
32. Linker R.A., Sendtner M., and Gold R. Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice. J Neurol Sci 233 (2005) 167-172
33. Imitola J., Snyder E.Y., and Khoury S.J. Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiol Genomics 14 (2003) 171-197
34. Totoiu M.O., Nistor G.I., Lane T.E., and Keirstead H.S. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol 187 (2004) 254-265
35. Blakemore W.F., Gilson J.M., and Crang A.J. Transplanted glial cells migrate over a greater distance and remyelinate demyelinated lesions more rapidly than endogenous remyelinating cells. J Neurosci Res 61 (2000) 288-294
36. Groves A.K., Barnett S.C., Franklin R.J., Crang A.J., Mayer M., Blakemore W.F., et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362 (1993) 453-455
37. Warrington A.E., Barbarese E., and Pfeiffer S.E. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 34 (1993) 1-13
38. Windrem M.S., Nunes M.C., Rashbaum W.K., Schwartz T.H., Goodman R.A., McKhann II G., et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10 (2004) 93-97
39. Bachelin C., Lachapelle F., Girard C., Moissonnier P., Serguera-Lagache C., Mallet J., et al. Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells. Brain 128 (2005) 540-549
40. Kohama I., Lankford K.L., Preiningerova J., White F.A., Vollmer T.L., and Kocsis J.D. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 21 (2001) 944-950
41. Barnett S.C., Alexander C.L., Iwashita Y., Gilson J.M., Crowther J., Clark L., et al. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 123 Pt 8 (2000) 1581-1588
42. Imaizumi T., Lankford K.L., Waxman S.G., Greer C.A., and Kocsis J.D. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci 18 (1998) 6176-6185
43. Akiyama Y., Radtke C., Honmou O., and Kocsis J.D. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39 (2002) 229-236
44. Brustle O., Jones K.N., Learish R.D., Karram K., Choudhary K., Wiestler O.D., et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285 (1999) 754-756
45. Chopp M., Zhang X.H., Li Y., Wang L., Chen J., Lu D., et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11 (2000) 3001-3005
46. Liu S., Qu Y., Stewart T.J., Howard M.J., Chakrabortty S., Holekamp T.F., et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 97 (2000) 6126-6131
47. McDonald J.W., Liu X.Z., Qu Y., Liu S., Mickey S.K., Turetsky D., et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5 (1999) 1410-1412
48. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 (2003) 688-694
49. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436 (2005) 266-271
50. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25 (2005) 4694-4705
51. Nistor G.I., Totoiu M.O., Haque N., Carpenter M.K., and Keirstead H.S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49 (2005) 385-396
52. Einstein O., Karussis D., Grigoriadis N., Mizrachi-Kol R., Reinhartz E., Abramsky O., et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 24 (2003) 1074-1082
53. Ben-Hur T., Einstein O., Mizrachi-Kol R., Ben-Menachem O., Reinhartz E., Karussis D., et al. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 41 (2003) 73-80
54. Bulte J.W., Ben-Hur T., Miller B.R., Mizrachi-Kol R., Einstein O., Reinhartz E., et al. MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn Reson Med 50 (2003) 201-205
55. Einstein O., Grigoriadis N., Mizrachi-Kol R., Reinhartz E., Polyzoidou E., Lavon I., et al. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198 (2006) 275-284
56. Martino G., and Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 7 (2006) 395-406
57. Ourednik J., Ourednik V., Lynch W.P., Schachner M., and Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 20 (2002) 1103-1110
58. Park K.I., Ourednik J., Ourednik V., Taylor R.M., Aboody K.S., Auguste K.I., et al. Global gene and cell replacement strategies via stem cells. Gene Ther 9 (2002) 613-624
59. Lu P., Jones L.L., Snyder E.Y., and Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181 (2003) 115-129
60. Kocsis J.D., Akiyama Y., and Radtke C. Neural precursors as a cell source to repair the demyelinated spinal cord. J Neurotrauma 21 (2004) 441-449
61. Bain G., Kitchens D., Yao M., Huettner J.E., and Gottlieb D.I. Embryonic stem cells express neuronal properties in vitro. Dev Biol 168 (1995) 342-357
62. Bain G., Ray W.J., Yao M., and Gottlieb D.I. Retinoic acid promotes neural and represses mesodermal gene expression in mouse embryonic stem cells in culture. Biochem Biophys Res Commun 223 (1996) 691-694
63. Fraichard A., Chassande O., Bilbaut G., Dehay C., Savatier P., and Samarut J. In vitro differentiation of embryonic stem cells into glial cells and functional neurons. J Cell Sci 108 Pt 10 (1995) 3181-3188
64. Strubing C., Ahnert-Hilger G., Shan J., Wiedenmann B., Hescheler J., and Wobus A.M. Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech Dev 53 (1995) 275-287
65. Finley M.F., Kulkarni N., and Huettner J.E. Synapse formation and establishment of neuronal polarity by P19 embryonic carcinoma cells and embryonic stem cells. J Neurosci 16 (1996) 1056-1065
66. Okabe S., Forsberg-Nilsson K., Spiro A.C., Segal M., and McKay R.D. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 59 (1996) 89-102
67. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., and McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18 (2000) 675-679
68. Rolletschek A., Chang H., Guan K., Czyz J., Meyer M., and Wobus A.M. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev 105 (2001) 93-104
69. Bibel M., Richter J., Schrenk K., Tucker K.L., Staiger V., Korte M., et al. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci 7 (2004) 1003-1009
70. Kawasaki H., Mizuseki K., Nishikawa S., Kaneko S., Kuwana Y., Nakanishi S., et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28 (2000) 31-40
71. Barberi T., Klivenyi P., Calingasan N.Y., Lee H., Kawamata H., Loonam K., et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 21 (2003) 1200-1207
72. Rathjen J., Haines B.P., Hudson K.M., Nesci A., Dunn S., and Rathjen P.D. Directed differentiation of pluripotent cells to neural lineages: homogeneous formation and differentiation of a neurectoderm population. Development 129 (2002) 2649-2661
73. Tropepe V., Hitoshi S., Sirard C., Mak T.W., Rossant J., and van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30 (2001) 65-78
74. Ying Q.L., Stavridis M., Griffiths D., Li M., and Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 21 (2003) 183-186
75. Conti L., Pollard S.M., Gorba T., Reitano E., Toselli M., Biella G., et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 3 (2005) e283
76. Glaser T., Pollard S.M., Smith A., and Brustle O. Tripotential differentiation of adherently expandable neural stem (NS) cells. PLoS ONE 2 (2007) e298
77. Chung S., Sonntag K.C., Andersson T., Bjorklund L.M., Park J.J., Kim D.W., et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 16 (2002) 1829-1838
78. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124 (2006) 393-405
79. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
80. Xian H., and Gottlieb D.I. Dividing Olig2-expressing progenitor cells derived from ES cells. Glia 47 (2004) 88-101
81. Du Z.W., Li X.J., Nguyen G.D., and Zhang S.C. Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression. Mol Cell Neurosci 33 (2006) 371-380
82. Jungling K., Nagler K., Pfrieger F.W., and Gottmann K. Purification of embryonic stem cell-derived neurons by immunoisolation. FASEB J 17 (2003) 2100-2102
83. Mayer-Proschel M., Kalyani A.J., Mujtaba T., and Rao M.S. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 19 (1997) 773-785
84. Mujtaba T., Piper D.R., Kalyani A., Groves A.K., Lucero M.T., and Rao M.S. Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev Biol 214 (1999) 113-127
85. Carpenter M.K., Inokuma M.S., Denham J., Mujtaba T., Chiu C.P., and Rao M.S. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172 (2001) 383-397
86. Li M., Pevny L., Lovell-Badge R., and Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol 8 (1998) 971-974
87. Wernig M., Tucker K.L., Gornik V., Schneiders A., Buschwald R., Wiestler O.D., et al. Tau EGFP embryonic stem cells: an efficient tool for neuronal lineage selection and transplantation. J Neurosci Res 69 (2002) 918-924
88. Schmandt T., Meents E., Gossrau G., Gornik V., Okabe S., and Brustle O. High-purity lineage selection of embryonic stem cell-derived neurons. Stem Cells Dev 14 (2005) 55-64
89. Glaser T., Perez-Bouza A., Klein K., and Brüstle O. Generation of purified oligodendrocyte progenitors from embryonic stem cells. FASEB J 19 (2005) 112-114 Electronic publication 2004 Oct 14
90. Zhang S.C. Neural subtype specification from embryonic stem cells. Brain Pathol 16 (2006) 132-142
91. Archer D.R., Cuddon P.A., Lipsitz D., and Duncan I.D. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nat Med 3 (1997) 54-59
92. Windrem M.S., Roy N.S., Wang J., Nunes M., Benraiss A., Goodman R., et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res 69 (2002) 966-975
93. Fancy S.P., Zhao C., and Franklin R.J. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27 (2004) 247-254
94. Arnett H.A., Fancy S.P., Alberta J.A., Zhao C., Plant S.R., Kaing S., et al. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306 (2004) 2111-2115
95. Zhou Q., Wang S., and Anderson D.J. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25 (2000) 331-343
96. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109 (2002) 75-86
97. Lu Q.R., Yuk D., Alberta J.A., Zhu Z., Pawlitzky I., Chan J., et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25 (2000) 317-329
98. Takebayashi H., Yoshida S., Sugimori M., Kosako H., Kominami R., Nakafuku M., et al. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 99 (2000) 143-148
99. Noble M., Proschel C., and Mayer-Proschel M. Getting a GR(i)P on oligodendrocyte development. Dev Biol 265 (2004) 33-52
100. Rowitch D.H., Lu Q.R., Kessaris N., and Richardson W.D. An 'oligarchy' rules neural development. Trends Neurosci 25 (2002) 417-422
101. Wu S., Wu Y., and Capecchi M.R. Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo. Development 133 (2006) 581-590
102. Zhou Q., Choi G., and Anderson D.J. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 31 (2001) 791-807
103. Tekki-Kessaris N., Woodruff R., Hall A.C., Gaffield W., Kimura S., Stiles C.D., et al. Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon. Development 128 (2001) 2545-2554
104. Takebayashi H., Ohtsuki T., Uchida T., Kawamoto S., Okubo K., Ikenaka K., et al. Non-overlapping expression of Olig3 and Olig2 in the embryonic neural tube. Mech Dev 113 (2002) 169-174
105. Zhou Q., and Anderson D.J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109 (2002) 61-73
106. Xin M., Yue T., Ma Z., Wu F.F., Gow A., and Lu Q.R. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25 (2005) 1354-1365
107. Lu Q.R., Cai L., Rowitch D., Cepko C.L., and Stiles C.D. Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex. Nat Neurosci 4 (2001) 973-974
108. Fu H., Qi Y., Tan M., Cai J., Takebayashi H., Nakafuku M., et al. Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation. Development 129 (2002) 681-693
109. Qi Y., Cai J., Wu Y., Wu R., Lee J., Fu H., et al. Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development 128 (2001) 2723-2733
110. Balasubramaniyan V., Timmer N., Kust B., Boddeke E., and Copray S. Transient expression of Olig1 initiates the differentiation of neural stem cells into oligodendrocyte progenitor cells. Stem Cells 22 (2004) 878-882
111. Marshall C.A., Novitch B.G., and Goldman J.E. Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells. J Neurosci 25 (2005) 7289-7298
112. Copray S., Balasubramaniyan V., Levenga J., de Bruijn J., Liem R., and Boddeke E. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes. Stem Cells 24 (2006) 1001-1010
113. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
114. Zhang S.C., Wernig M., Duncan I.D., Brustle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19 (2001) 1129-1133
115. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 19 (2001) 1134-1140
116. Izrael M., Zhang P., Kaufman R., Shinder V., Ella R., Amit M., et al. Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 34 (2007) 310-323
117. Kang S.M., Cho M.S., Seo H., Yoon C.J., Oh S.K., Choi Y.M., et al. Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 25 (2007) 419-424
118. Wichterle H., Lieberam I., Porter J.A., and Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110 (2002) 385-397
119. Zhang X., Cai J., Klueber K.M., Guo Z., Lu C., Qiu M., et al. Induction of oligodendrocytes from adult human olfactory epithelial-derived progenitors by transcription factors. Stem Cells 23 (2005) 442-453
120. Mekki-Dauriac S., Agius E., Kan P., and Cochard P. Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 129 (2002) 5117-5130
121. Samanta J., and Kessler J.A. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131 (2004) 4131-4142
122. Schmandt T., Goßrau G., Kischlat T., Opitz T., and Brüstle O. Animal models for cell and gene therapy in myelin disease. Drug Discovery Today: Disease Models 3 (2006) 349-358
123. Boison D., and Stoffel W. Myelin-deficient rat: a point mutation in exon III (A-C, Thr75-Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. EMBO J 8 (1989) 3295-3302
124. Csiza C.K., and de Lahunta A. Myelin deficiency (md): a neurologic mutant in the Wistar rat. Am J Pathol 95 (1979) 215-223
125. Bird T.D., Farrell D.F., and Sumi S.M. Brain lipid composition of the shiverer mouse: (genetic defect in myelin development). J Neurochem 31 (1978) 387-391
126. Yajima K., and Suzuki K. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest 41 (1979) 385-392
127. Woodruff R.H., and Franklin R.J. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25 (1999) 216-228
128. Matsushima G.K., and Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11 (2001) 107-116
129. Morell P., Barrett C.V., Mason J.L., Toews A.D., Hostettler J.D., Knapp G.W., et al. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 12 (1998) 220-227
130. Hinks G.L., Chari D.M., O'Leary M.T., Zhao C., Keirstead H.S., Blakemore W.F., et al. Depletion of endogenous oligodendrocyte progenitors rather than increased availability of survival factors is a likely explanation for enhanced survival of transplanted oligodendrocyte progenitors in X-irradiated compared to normal CNS. Neuropathol Appl Neurobiol 27 (2001) 59-67
131. Perez-Bouza A., Glaser T., and Brüstle O. ES cell-derived glial precursors contribute to remyelination in acutely demyelinated spinal cord lesions. Brain Pathol 15 (2005) 208-216
132. Gold R., Hartung H.P., and Toyka K.V. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 6 (2000) 88-91
133. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., and Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol 20 (2002) 101-123
134. Izikson L., Klein R.S., Luster A.D., and Weiner H.L. Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol 103 (2002) 125-131
135. Ben-Nun A., Wekerle H., and Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11 (1981) 195-199
136. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194 (2001) 669-676
137. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166 (2001) 7579-7587
138. Ji Q., and Goverman J. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells. Ann N Y Acad Sci 1103 (2007) 157-166
139. Stromnes I.M., and Goverman J.M. Active induction of experimental allergic encephalomyelitis. Nat Protocols 1 (2006) 1810-1819
140. Tourbah A., Linnington C., Bachelin C., Avellana-Adalid V., Wekerle H., and Baron-Van Evercooren A. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats. J Neurosci Res 50 (1997) 853-861
141. Ben-Hur T., van Heeswijk R.B., Einstein O., Aharonowiz M., Xue R., Frost E.E., et al. Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn Reson Med 57 (2007) 164-171
142. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101 (2004) 18117-18122
143. Friese M.A., Montalban X., Willcox N., Bell J.I., Martin R., and Fugger L. The value of animal models for drug development in multiple sclerosis. Brain 129 (2006) 1940-1952
144. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
145. Zhang Y.W., Denham J., and Thies R.S. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 15 (2006) 943-952
146. Lacorazza H.D., Flax J.D., Snyder E.Y., and Jendoubi M. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med 2 (1996) 424-429
147. Shihabuddin L.S., Numan S., Huff M.R., Dodge J.C., Clarke J., Macauley S.L., et al. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology. J Neurosci 24 (2004) 10642-10651
148. Snyder E.Y., Taylor R.M., and Wolfe J.H. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374 (1995) 367-370
149. Givogri M.I., Galbiati F., Fasano S., Amadio S., Perani L., Superchi D., et al. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci 26 (2006) 3109-3119
150. Meng X.L., Shen J.S., Ohashi T., Maeda H., Kim S.U., and Eto Y. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. J Neurosci Res 74 (2003) 266-277
151. Kawabata K., Migita M., Mochizuki H., Miyake K., Igarashi T., Fukunaga Y., et al. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Brain Res 1094 (2006) 13-23
152. Taylor R.M., Lee J.P., Palacino J.J., Bower K.A., Li J., Vanier M.T., et al. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy. J Neurochem 97 (2006) 1585-1599
153. Hess B., Saftig P., Hartmann D., Coenen R., Lullmann-Rauch R., Goebel H.H., et al. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci U S A 93 (1996) 14821-14826
154. Klein D., Schmandt T., Muth-Kohne E., Perez-Bouza A., Segschneider M., Gieselmann V., et al. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther 13 (2006) 1686-1695
155. Matzner U., Hartmann D., Lullmann-Rauch R., Coenen R., Rothert F., Mansson J.E., et al. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. Gene Ther 9 (2002) 53-63
156. Matzner U., and Gieselmann V. Gene therapy of metachromatic leukodystrophy. Expert Opin Biol Ther 5 (2005) 55-65
157. Lee J.P., Jeyakumar M., Gonzalez R., Takahashi H., Lee P.J., Baek R.C., et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med 13 (2007) 439-447
158. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11 (2005) 25-36
159. Fedele D.E., Koch P., Scheurer L., Simpson E.M., Mohler H., Brustle O., et al. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 370 (2004) 160-165
160. Guttinger M., Fedele D., Koch P., Padrun V., Pralong W.F., Brustle O., et al. Suppression of kindled seizures by paracrine adenosine release from stem cell-derived brain implants. Epilepsia 46 (2005) 1162-1169
161. Li T., Steinbeck J.A., Lusardi T., Koch P., Lan J.Q., Wilz A., et al. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130 (2007) 1276-1288
162. Miller R.H. The promise of stem cells for neural repair. Brain Res 1091 (2006) 258-264
163. Bjorklund A., and Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3 (2000) 537-544
164. Goldman S.A., and Windrem M.S. Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci 361 (2006) 1463-1475
165. Lindvall O., and Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 441 (2006) 1094-1096
166. Yandava B.D., Billinghurst L.L., and Snyder E.Y. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci U S A 96 (1999) 7029-7034
167. Learish R.D., Brustle O., Zhang S.C., and Duncan I.D. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann Neurol 46 (1999) 716-722
168. Belmadani A., Tran P.B., Ren D., and Miller R.J. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 26 (2006) 3182-3191
169. Chang A., Tourtellotte W.W., Rudick R., and Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346 (2002) 165-173
170. Franklin R.J. Remyelination of the demyelinated CNS: the case for and against transplantation of central, peripheral and olfactory glia. Brain Res Bull 57 (2002) 827-832
171. Lassmann H., Bruck W., and Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7 (2001) 115-121
172. Lucchinetti C.F., Bruck W., and Lassmann H. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56 (2004) 308